Human parvovirus B19 infection associated with idiopathic thrombocytopenic purpura in a child following liver transplantation

被引:31
作者
Assy, N
Rosenthal, E
Hazani, A
Etzioni, A
Baruch, Y
机构
[1] TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,LIVER UNIT,IL-31096 HAIFA,ISRAEL
[2] TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,DEPT PEDIAT A,IL-31096 HAIFA,ISRAEL
[3] TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,HEMATOL CLIN,IL-31096 HAIFA,ISRAEL
[4] TECHNION ISRAEL INST TECHNOL,RAMBAM MED CTR,DEPT MED B,IL-31096 HAIFA,ISRAEL
[5] TECHNION ISRAEL INST TECHNOL,BRUCE RAPPAPORT FAC MED,IL-31096 HAIFA,ISRAEL
关键词
FK; 506; idiopathic thrombocytopenic purpura; immunosuppression; liver transplantation; parvovirus B19;
D O I
10.1016/S0168-8278(97)80334-0
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background/Aims: Idiopathic (autoimmune) thrombocytopenic purpura has been previously reported as a rare complication in children following parvovirus B19 infection, If the immunocompromised host who is unable to produce neutralizing antibody, an infection with parvovirus B19 can persist and cause chronic bone marrow failure. Methods: We describe a child who had undergone liver transplantation and who had idiopathic thrombocytopenic purpura, whose history and laboratory findings suggested parvovirus B19 infection, The infection disappeared without persistent viremia, and the thrombocytopenia responded completely to the administration of gamma globulin while the patient was undergoing chromic immunosuppression therapy. Results/Conclusion: Transplant physicians need to be aware of this complication, and parvovirus B19 infection should be included in the differential diagnosis of liver recipients presenting with severe thrombocytopenia.
引用
收藏
页码:934 / 936
页数:3
相关论文
共 19 条
[1]   Immunopathology or organ-specific autoimmunity as a consequence of virus infection [J].
Aichele, P ;
Bachmann, MF ;
Hengartner, H ;
Zinkernagel, RM .
IMMUNOLOGICAL REVIEWS, 1996, 152 :21-45
[2]  
ARNOLD JC, 1993, TRANSPLANTATION, V56, P1286
[3]   HUMAN PARVOVIRUS-B19 INFECTION IN BONE-MARROW TRANSPLANTATION PATIENTS [J].
AZZI, A ;
FANCI, R ;
CIAPPI, S ;
ZAKRZEWSKA, K ;
BOSI, A .
AMERICAN JOURNAL OF HEMATOLOGY, 1993, 44 (03) :207-209
[4]  
CARTON EG, 1991, TRANSPLANT P, V23, P1938
[5]   TRANSIENT REVERSAL OF THROMBOCYTOPENIA IN IDIOPATHIC THROMBOCYTOPENIC PURPURA BY HIGH-DOSE INTRAVENOUS GAMMA-GLOBULIN [J].
FEHR, J ;
HOFMANN, V ;
KAPPELER, U .
NEW ENGLAND JOURNAL OF MEDICINE, 1982, 306 (21) :1254-1258
[6]   PARVOVIRUS-B19 FOR THE HEMATOLOGIST [J].
HARRIS, JW .
AMERICAN JOURNAL OF HEMATOLOGY, 1992, 39 (02) :119-130
[7]   TACROLIMUS - A NEW IMMUNOSUPPRESSIVE AGENT [J].
KELLY, PA ;
BURCKART, GJ ;
VENKATARAMANAN, R .
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1995, 52 (14) :1521-1535
[8]  
KURTZMAN GJ, 1988, LANCET, V2, P1159
[9]   CHRONIC BONE-MARROW FAILURE DUE TO PERSISTENT B19-PARVOVIRUS INFECTION [J].
KURTZMAN, GJ ;
OZAWA, K ;
COHEN, B ;
HANSON, G ;
OSEAS, R ;
YOUNG, NS .
NEW ENGLAND JOURNAL OF MEDICINE, 1987, 317 (05) :287-294
[10]  
LOUACHE F, 1991, BLOOD, V78, P1697